Otonomy
Latest round
- Series D
Last raised
- Apr 2014
Total raised
- $108M
Investors
- 13
About Otonomy
Otonomy Inc.Founded in 2008, Otonomy Inc. is based in San Diego, US, and operates in the field of otology, providing groundbreaking treatments for ear-related conditions. The company was founded by Allen Ryan, who has a history of involvement in the biotechnology sector.Otonomy Inc. offers a range of therapies aimed at treating ear diseases, particularly focusing on drug delivery systems for conditions like hearing loss and tinnitus.In the most recent fiscal year ending 2021, Otonomy reported a revenue of USD 125,000, alongside an EBITDA of USD -48,512,000.Otonomy Inc. is strategically planning to expand its product offerings with new therapies set to launch in the upcoming years, targeting global markets with significant unmet medical needs. The company has identified Europe and Asia as key regions for expansion by 2023.
Who invested in Otonomy
13 investors across 4 rounds
See all investors in Otonomy
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Otonomy
Who invested in Otonomy?
Otonomy has 13 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Otonomy raised?
Otonomy has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Otonomy last raise money?
Otonomy's most recent round on record is a Series D, in Apr 2014.
What does Otonomy do?
Otonomy is a biotechnology company.
Where is Otonomy headquartered?
Otonomy is headquartered in San Diego, US.
Which VCs invest in companies like Otonomy?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Otonomy's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Otonomy? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.